The 'Dispatched' Podcast
BioPharmaDispatch - discussing the issues impacting the Australian biopharmaceutical and life sciences sectors with Paul Cross and Felicity McNeill.
The 'Dispatched' Podcast
Latest Episodes
The 'Dispatched' Podcast - Series 5. Ep.29
The opportunities available in the pending negotiation of new industry agreements and the selective discrimination against some patients and patient groups by an outdated and unaccountable institution.
The 'Dispatched' Podcast - Series 5. Ep.28
For more than a decade, Public Summary Documents have been presented as evidence of system transparency, but in fact, they are an affront to it. What was the discussion about transparency that ended with an impenetrable 50-page technical docume...
The 'Dispatched' Podcast - Week in review
An important reminder about the impact of innovation and why it matters. What does it say about Australia and our life sciences policy frameworks that locally developed innovations are commercialised in other markets, but not here? Patients nee...
The 'Dispatched' Week in Review'- 31 July (Series 5, Ep.26)
The events in the US this week surrounding a former public health leader raise some important questions in Australia about the accountability of 'independent experts'. Why we can't afford to muck up the AI opportunity as new evidence on its use...
The 'Dispatched' Podcast - Series 5, Ep.25
Misleading claims about patient groups and the industry, combined with an irrational hyperventilation about a rational response to new global realities, have made for an interesting week. The price reduction mantra and whether it can be moderat...